维普中文期刊产品整合服务
509篇 您的检索式:作者名="infarction"
    题名 作者 年代 出处 被引量
1重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验显示文摘目的研究新型溶栓剂——重组葡激酶(r-Sak)治疗急性心肌梗死(AMI)的冠状动脉通畅率、临床疗效及安全性。方法本研究为多中心、随机、平行对照临床试验,入选发病12 h 内、年龄≤70岁、ST 段抬高的 AMI 患者,随机分为 r-Sak 组104例,给予 r-Sak 3 mg 静注,12 mg 于30 min 内静脉输注,总量15 mg;重组组织型纤溶酶原激活剂(rt-PA)组106例,8 mg 静注,42 mg 在90 min 内输注,总量50 mg。全部患者给予阿司匹林和静脉输注肝素,于用药90 min 行冠状动脉造影,对 TIMI 血流0~2级者行补救性 PCI。结果主要终点:用药90 min 冠状动脉通畅率(TIMI 血流2级或3级),r-Sak 组明显高于 rt-PA 组(77.8%比63.6%,P=0.0277),TIMI 3级者两组间差异无统计学意义(57.6%比48.5%,P=0.1929);1个月内死亡(8.7%比5.7%,P=0.3997)、非致死性再梗死(2.9%比3.8%,P=1.0000)、心肌缺血复发(8.7%比16.0%,P=0.1043)和复合临床终点(18.3%比21.7%,P=0.5345)两组间差异均无统计学意义。次要终点:r-Sak 组出血发生率(28.8%)与 rt-PA组(27.4%)比较,差异无统计学意义(P=0.8105),其中严重或威胁生命的出血,两组间差异亦无统计学意义(1.9%比3.8%),r-Sak 组脑出血1例(0.96%),rt-PA 组脑出血4例(3.85%)。无其他药物相关的严重不良反应及过敏反应发生。结论 r-Sak 是一种安全、有效的治疗 AMI 的溶栓药物,其疗效及安全性至少与 rt-PA 50 mg 相似。Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction 2007中华心血管病杂志2007,35,8:43
290分钟冠状动脉造影评价急性心肌梗塞血管开通及临床再通指标价值显示文摘通过经静脉溶栓开始后90分钟冠状动脉造影(CAG),观察国产尿激酶(天普洛欣,UKTP)静脉溶栓治疗急性心肌梗塞(AMI)血管开通疗效,并评价临床再灌注标准的判断价值如何。方法:从UKTP多中心治疗AMI1406例中,汇集其中所行冠状动脉造影(CAG)共124例资料。结果提示:(1)124例AMI患者,在溶栓开始后90分钟时的梗塞相关血管的血流达TIMIⅢ级者52例(41.9%)、Ⅱ级38例(30.7%),梗塞相关血管再开通率为72.6%;(2)溶栓距起病时间愈早,具有愈高的开通趋势,但差异无统计学意义;(3)以CAG为金标准,临床标准对血管开通判断敏感性为88%,特异性为69%,准确性为83%。结论:UKTP静脉溶栓治疗AMI血管开通疗效肯定,临床标准判断血管再通的敏感性较高,但特异性欠佳,有待提高。The multicentre investigating group of thrombolytic therapy on acute myocardial infarction with Urokinase Techpool Correspondence: Hu Dayi, Xu Zhimin. Chaoyang Red Cross Hospital, Capital University of Medical Sciences, Beijing 100020 1997中华心血管病杂志1997,25,4:11
3急性高血糖对ST段抬高性心肌梗死院内预后的影响显示文摘目的探讨急性高血糖对 ST 段抬高性心肌梗死(STEMI)患者院内预后的影响。方法连续入选356例北京地区17家三级和二级医院所有在24h 内入院且符合 STEMI 诊断标准的患者。以人院血糖水平>11mmol/L 判定为高血糖,分为高血糖组和血糖正常组,观察两组患者院内死亡和心血管病事件的发生情况。院内心血管事件定义为院内再发心肌梗死、新发生的心力衰竭、严重心律失常及卒中。结果 356例 STEMI 患者中,存在急性高血糖患者共81例(22.8%)。其院内病死率较无急性高血糖患者显著增加(13.6%比5.1%,P=0.009),院内心血管事件发生率亦显著增多(32.1%比20.4%,P=0.027)。logistic 回归分析示,入院急性高血糖(OR 1.615,95%CI 1.116~2.338,P=0.011)为 STEMI 患者院内不良预后的独立危险因素。结论 STEMI 急性高血糖患者院内死亡及发生院内心血管事件的危险性显著高于入院血糖正常者。入院高血糖为 STEMI 患者院内不良预后的独立危险因素。Registry of acute treatment in myocardial infarction investigators. 2007中华内科杂志2007,46,10:9
4Randomised trial of intravenous Streptokinase,oral aspirin,both,or,neithcr among 17,187 cases of suspected acute myocardial infarction: ISIS-2 显示文摘Collins R Yusuf S ISIS-2 ( Second International Study of Infarct Survival Collaborative Group ) Lancet0,,:2
5Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction显示文摘ISIS-2( Second Intemational Study of Infarct Survival)Collaborative Group 1988lancet1988,345,8613:1
6A report of the American college of/American heart association task force on practice guidelines显示文摘ACC/HAH guidelines for the management of patiens with unstable angina and non- ST - segment elevation myocardial infarction 2000JACC2000,36,:1
7Circulation显示文摘Hama N Rapid ventricular induction ofbrain natriuretic peptide geneexpression in experimental acute myocardial infarction 199592(6): 1558- 15641995,92,6:1
8ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST - segment elevation 显示文摘Task Force on the management of ST - segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ) Steg PG James SK 2012Eur Heart J2012,33,20:1
9A Report of American College of Cardiology/American Heart Association Task Force or Practice Guidelines显示文摘ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation mycardical infarction 2000GACC2000,36,2:1
10A report American collage of cardiology/American heart association task force or practice guidelines显示文摘ACC/AHA·Guidelines for the management of patientswith unstable angina and non-st-segment elevation myocardial infarction 2000J Am Coll Cardiol2000,,36:1
11Effect of a novel free radical scavenger,edaravone(MCl-186),on acute brain infarction, randomized, placebc - controlled, doubleblind study at mutticenters显示文摘Edaravone acute infarction study group 2003Cerebrovasc Dis2003,15,3:1
12Myocardial infarction redefined a consensus docrument of The Joint European Society of Cardiology/American College of Cardioloty Committee for the redefinition of myocardial infarction 显示文摘The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction 2000J Am Coil Cardiol2000,36,:1
13Effect of a novel free radical cavenger,Eedaravone(MCI-186),on acute brain infarction,andonized,placebo controlled,double blind study at multicenters显示文摘Edaravone acute infarction study group 2003Cerebrobasc Dis2003,15,12:1
14Effect of aNovel Free Radical,Edaravone (MCI-186),on Acute Brain Infarction Randomized,Placebo-Controlled,Double-Blind Study at Multicenters the Edaravone显示文摘The Edaravoe Acute Brain Infarction Study Group 2003Cerebralvasc Dis2003,15,3:1
15The SCATI (Studio sulla Calciparina nell'Angina e nella Trombosi Ventricolare nell'Infarto) Group显示文摘Randomised controlled trial of subcutaneous calcium- heparin in acute myocardial infarction 1989Lancet1989,2,8656:1
16The GUSTO investigators显示文摘An international randomized trial comparing four thrombolytic strate gies for acute myocardial infarction 1993N Engl JM ed1993,329,10:1
17Effect of a Novel Free Radical Scavenger, Edaravone (MCI- 186), on Acute Brain Infarction 显示文摘Edaravone Acute Brain Infarction Study Group 2003Cerebrovasc Dis2003,15,3:1
18Meeting highlights显示文摘ISIS-4 fourth international study of infarct survival Ferguson Ⅱ 2009Circulation2009,89,:1
19Effect of a novel free radical scavenger,edaravone (MCI-186),on acute brain infarction显示文摘Edaravone Acute Brain Infarction Study Group 2003Cerebrovasc Dis2003,15,:1
20A report of American college of cardiology/American heart association task force or practice guidelines显示文摘ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction 2000J Am Coll Cardiol2000,36,:1
返回顶部 每页显示:
共26页 首页 上一页 第1页 下一页 末页 /26 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费